Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
oleh: Roy Fleischmann, Patrick Durez, Yoshiya Tanaka, Eduardo Mysler, Louis Bessette, Yihan Li, In-Ho Song, Nasser Khan, Charles G Peterfy, Jerzy Swierkot, Xianwei Bu
Format: | Article |
---|---|
Diterbitkan: | BMJ Publishing Group 2022-02-01 |
Deskripsi
No description available for this item.